Spondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative disease
Authors:
- John A. OlanrewajuJOJohn A. Olanrewaju
- Leviticus O. ArietarhireLALeviticus O. Arietarhire
- Oladimeji E. SoremekunOSOladimeji E. Soremekun
- Ezekiel A. OlugbogiEOEzekiel A. Olugbogi
- Toluwanimi O. AfolabiTAToluwanimi O. Afolabi
- Babatunji E. OyinloyeBOBabatunji E. Oyinloye
- Olaposi I. OmotuyiOOOlaposi I. Omotuyi
- Steven RussellSRSteven Russell
Preprint
- 29 December 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Spondias mombin (S. mombin), a prominent botanical resource, has garnered recognition within folkloric therapy. Parkinson's disease (PD), characterized by dopaminergic neuron attrition in the substantia nigra, manifests as motor anomalies like tremors, rigidity, and bradykinesia. This study capitalizes on S. mombin's reservoir of 100 characterized phytocompounds and employs computational methodologies to interrogate their potential 35 PD-associated target proteins. Employing a multifaceted approach, we engaged in molecular docking, ADMET predictions, Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) evaluations, Density Functional Theory (DFT), and Molecular Dynamic Simulations (MDS). This comprehensive framework facilitated insightful structural assessments and predictive analyses. Impressively, flavonoids hailing from S. mombin, including quercetin, catechin, ellagic acid, and epicatechin, showcased optimal binding affinities for PD-relevant target proteins. Moreover, these identified ligands exhibited minimal signs of mutagenicity, tumorigenicity, or irritancy, except for quercetin, which displayed elevated tumorigenic potential. Notably, quercetin and dopamine exhibited varying band gap energies, with quercetin the lowest (3.63 eV) and dopamine the highest (5.76 eV) values. MDS result suggests a synergistic outcome based on the RMSD and RMSF graphs for quercetin highlighting it as the best of all including the co-ligand. In a collective sense, our findings present S. mombin as promising reservoirs of active pharmaceutical ingredients, warranting further exploration for novel PD therapeutic avenues. Consequently, this study underscores the enhanced efficacy of phyto-ligands sourced from S. mombin, advocating their optimization as potential drug candidates.Keywords
All Related Versions
This publication has 72 references indexed in Scilit:
- Exploring the Composition of Protein-Ligand Binding Sites on a Large ScalePLOS Computational Biology, 2013
- The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in InflammationGenes, 2013
- Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and CaffeineStructure, 2011
- X-ray crystal structure of JNK2 complexed with the p38α inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- A Normative Study of the Components of Niprisan—an Herbal Medicine for Sickle Cell AnemiaJournal of Dietary Supplements, 2010
- Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson’s disease factors Pink1 and ParkinDisease Models & Mechanisms, 2008
- Systems biology in drug discoveryNature Biotechnology, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Structural Characterization of the GSK-3β Active Site Using Selective and Non-selective ATP-mimetic InhibitorsJournal of Molecular Biology, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001